Client	Transaction Details	Value (US$ mn)	Year
Max Healthcare	Merger of Radiant Life Care	1,200	2018
Dr. Reddy's Laboratories	Manager to the Buyback Offer to the shareholders of Dr. Reddy's Laboratories Limited via Open Market route	234	2016
Laurus Labs	Book Running Lead Manager for IPO	197	2016
Healthcare Global Enterprises	Book Running Lead Manager for IPO	100	2016
TPG Capital	Financial Advisor to TPG Capital for investment in Manipal Health Enterprises	150	2015
Dr Lal PathLabs	Book Running Lead Manager for IPO	94	2015
Glaxo Smithkline Pharmaceuticals	Open Offer for Glaxo Smithkline Pharmaceuticals	1,065	2014
Actis	Sale of controlling stake in Sterling Hospitals	Undisclosed	2014
Bausch & Lomb Eyecare India	Bausch & Lomb Eyecare India Ltd divested its Ophthalmology Portfolio to Ipca Laboratories Ltd	Undisclosed	2014
B. Braun	Delisting Offer for Ahlcon Parenterals (India) Limited	16	2014
Torrent Pharmaceuticals	Acquisition of the Indian formulation business of Elder Pharmaceuticals by Torrent Pharmaceuticals	322	2013
Mitsui – Arch Pharmalabs Limited	Mitsui & Co., Ltd. has acquired an additional 27.29% of the shares of Arch Pharmalabs Limited for US$ 68 million taking their post transaction shareholding to 31.96%. Kotak Investment Banking and GCA Savvian Corporation were the Exclusive Financial Advisors to Mitsui & Co., Ltd. for the transaction.	68	2013
Trivitron Healthcare	Exclusive financial advisor to Trivitron for private equity investment by Fidelity Growth Partners India	75	2012
Super Religare Laboratories	Financial advisor to Super Religare Laboratories for private equity investment by Jacob Ballas and International Finance Corporation (IFC),	67	2012
Super Religare Laboratories	Financial advisor for private equity investment in Super Religare Laboratories by Avigo and Sabre Capital	30	2011
Piramal Healthcare	Manager to buyback of equity shares	551	2010
Jubilant Organosys	Business Restructuring and Fairness Opinion	-	2010
Strides Arcolab	Book Running Lead Manager for QIP	99.8	2010
Jubilant Organosys	Book Running Lead Manager to the QIP	84.8 mn	2010
Cipla	Exclusive Advisor to Cipla Limited for acquisition of Meditab Private Limited	29	2010
Cipla	Exclusive financial advisor to Cipla for sale of all Intellectual property rights in India related to Cipla's "i-pill" brand to Piramal Healthcare	21	2010
Cipla	Qualified Institutional Placement	142	2009
Apollo Hospitals Enterprise Ltd	Preferential Allotment of up to 12% stake by Apollo Hospitals Enterprise Ltd to Apax Partners	104	2007
Fortis	Initial Public Offering	121	2007
Cipla	GDR Issue	170	2006
Vimta Labs	Private equity placement with portfolio funds through preferential allotment route	17.4	2006
Apollo Hospitals Enterprise Ltd	GDR Issue	70	2005
Nicholas Piramal	Rights Issue	76.4	2005